BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10912964)

  • 1. Management of pregnancies complicated by anti-Kell isoimmunization.
    McKenna DS; Nagaraja HN; O'Shaughnessy R
    Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pregnancies complicated by anti-c isoimmunization.
    Hackney DN; Knudtson EJ; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2004 Jan; 103(1):24-30. PubMed ID: 14704240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A; Lapinski RH; Berkowitz RL
    Am J Perinatol; 1998; 15(12):695-701. PubMed ID: 10333397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
    Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
    Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
    Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP; Widness JA
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Kell blood group alloimmunization.
    Bowman JM; Pollock JM; Manning FA; Harman CR; Menticoglou S
    Obstet Gynecol; 1992 Feb; 79(2):239-44. PubMed ID: 1731292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kell sensitization in pregnancy.
    Caine ME; Mueller-Heubach E
    Am J Obstet Gynecol; 1986 Jan; 154(1):85-90. PubMed ID: 3946507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
    van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
    Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic disease of the newborn due to anti-Jsb.
    Purohit DM; Taylor HL; Spivey MA
    Am J Obstet Gynecol; 1978 Aug; 131(7):755-6. PubMed ID: 686069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of anti-Kell sensitization in pregnancy.
    Mayne KM; Bowell PJ; Pratt GA
    Clin Lab Haematol; 1990; 12(4):379-85. PubMed ID: 2081378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of extended analysis of serum, amniotic fluid and cardiotocography in the management of pregnancy complicated by immunization in Rh or Kell antigens.
    Woytoń J; Narczewska B; Gajewska E; Baranowski H; Kwoczyńska K; Dzierzkowa-Borodej W; Partyka T; Bochenek S; Lochocka E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1131-7. PubMed ID: 107916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal anti-Kell isoimmune hemolytic disease with spherocytes.
    Merlob P; Reisner SH; Zaizov R
    Pediatr Hematol Oncol; 1986; 3(2):175-8. PubMed ID: 3153228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.